A detailed history of Souders Financial Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Souders Financial Advisors holds 8,016 shares of MRK stock, worth $1.01 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
8,016
Previous 9,079 11.71%
Holding current value
$1.01 Million
Previous $989,000 6.88%
% of portfolio
0.17%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $120,374 - $140,262
-1,063 Reduced 11.71%
8,016 $1.06 Million
Q4 2023

Jan 24, 2024

SELL
$100.18 - $109.02 $371,367 - $404,137
-3,707 Reduced 28.99%
9,079 $989,000
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $15,854 - $17,606
154 Added 1.22%
12,786 $1.32 Million
Q2 2023

Aug 09, 2023

BUY
$108.61 - $118.38 $450,405 - $490,921
4,147 Added 48.87%
12,632 $1.46 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $505,538 - $564,077
-4,911 Reduced 36.66%
8,485 $902,000
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $9,006 - $11,547
-103 Reduced 0.76%
13,396 $1.49 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $118,849 - $133,513
1,406 Added 11.63%
13,499 $1.16 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $2.35 Million - $2.66 Million
-28,112 Reduced 69.92%
12,093 $1.1 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $2.96 Million - $3.31 Million
40,205 New
40,205 $3.3 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $405,572 - $450,102
-5,651 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $38,931 - $44,129
532 Added 10.39%
5,651 $458,000
Q2 2020

Aug 11, 2020

SELL
$70.42 - $80.13 $48,589 - $55,289
-690 Reduced 11.88%
5,119 $396,000
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $368,058 - $510,146
5,809 New
5,809 $447,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Souders Financial Advisors Portfolio

Follow Souders Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.